BridgeBio Pharma, Inc. BBIO
$66.33
▼ -1.11% 24H
About
BridgeBio Pharma, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for patients with genetic diseases and genetically driven cancers. The company concentrates on conditions with well-defined genetic causes, aiming to design targeted therapies that address the underlying molec…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees834
TickerBBIO
Statistics
Market Cap$12.98B
Revenue (TTM)$502.1M
Net Income-$732.9M
Net Margin-146.0%
EPS$-3.78
P/E-17.79
P/S22.81
P/B-5.77
EV/EBITDA-29.65
ROE34.9%
Dividend Yield—
Price$66.33
Data: Twelve Data · Revenue = mcap / P/S